Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rural cancer research activity across Europe: A bibliometric analysis on patterns, gaps and policy implications.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2026
Same author

Media representations of rural and coastal cancer inequalities in the UK: A 10-year retrospective place-based analysis.

Health & place·2026
Same author

Coastal cancer care: A blueprint to address the unmet needs through place-based research and policy approaches.

Journal of cancer policy·2026
Same author

Coral larvae have unique transcriptomic responses to pathogenic and probiotic bacteria.

Coral reefs (Online)·2026
Same author

Toward Causal Relationships of Intracranial Pressure, Cerebrovascular Reactivity, Interventions, and Outcome in Severe Traumatic Brain Injury: A CENTER-TBI High-Resolution Substudy.

Neurocritical care·2026
Same author

Chronic Comparison of Short Recovery Stress Scale in Trained Individuals Completing Traditional or Accentuated Eccentric Loading.

Journal of strength and conditioning research·2026

Related Experiment Video

Updated: Jul 5, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Ribavirin considerations in treatment optimization.

Geoffrey Dusheiko1, David Nelson, K Rajender Reddy

  • 1Royal Free Hospital, London, United Kingdom.

Antiviral Therapy
|April 25, 2008
PubMed
Summary
This summary is machine-generated.

Optimizing ribavirin dosage in hepatitis C virus (HCV) treatment significantly boosts sustained virological response (SVR) rates. Balancing ribavirin efficacy with its side effects, like hemolytic anemia, is key for better patient outcomes.

More Related Videos

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
18:10

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

Published on: June 16, 2011

Related Experiment Videos

Last Updated: Jul 5, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
18:10

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

Published on: June 16, 2011

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Ribavirin, a guanosine analogue, has limited antiviral activity alone.
  • It significantly enhances interferon-based therapies for hepatitis C virus (HCV).
  • Its exact mechanism in achieving sustained virological response (SVR) is not fully elucidated.

Purpose of the Study:

  • To discuss optimizing ribavirin dosage in combination therapy for HCV.
  • To highlight the importance of ribavirin in achieving high SVR rates.
  • To address the balance between ribavirin efficacy and its side effects.

Main Methods:

  • Review of existing studies on ribavirin dosing and SVR rates.
  • Analysis of ribavirin's pharmacokinetic profile and side effects.
  • Discussion on optimizing ribavirin component in combined HCV therapy.

Main Results:

  • Higher initial ribavirin doses correlate with increased SVR rates.
  • Intensified dosing may improve outcomes in difficult-to-cure HCV patients.
  • Minimizing dose reductions and maintaining ribavirin levels are crucial for preventing relapse.

Conclusions:

  • Optimizing ribavirin dosage is essential for maximizing SVR in HCV treatment.
  • Balancing efficacy and side effects (e.g., hemolytic anemia) is critical for patient outcomes.
  • Effective ribavirin management is a key component of overall HCV treatment optimization.